Vizionfocus Inc. (4771) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Vizionfocus Inc. stock TWD 293, price TWD 180, upside +62.9%, quality 44 out of 100. Rating: strongly undervalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range 78.06 TWD – 334.23 TWD · fair‑value band 219.88 TWD – 366.46 TWD · the 180.00 TWD price screens below the 293.17 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.
Follow Vizionfocus in your weekly email
Every Wednesday you see whether Vizionfocus is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Vizionfocus Inc. engages in the manufacturing of medical equipment in Japan, China, Southeast Asia and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services.
Show moreShow less
In addition, the company engages in the research and development, design, OEM, development, and sale of contact lenses, as well as customized services. Vizionfocus Inc. was founded in 2012 and is headquartered in Miaoli, Taiwan.
Stock analysis
Vizionfocus Inc. (4771) currently trades at 180.00 TWD, while our model-based Fair Value estimate is 293.17 TWD, implying the stock looks roughly 39% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 444.09 TWD per share, and 10 of the 16 models we run sit above the 180.00 TWD price.
Bear case: the Asset-Based group reads lowest at 43.65 TWD, and 6 of the 16 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 219.88 TWD (bear) to 366.46 TWD (bull), the price of 180.00 TWD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Vizionfocus Inc. reported revenue of 3.5B TWD in FY2025 versus 1.4B TWD in FY2021, a compound +25.2%/yr. Reported net income was 808M TWD in FY2025, compounding +36.3%/yr from FY2021.
Key figures
Market cap 11.4B TWD (≈ $349M) Small · P/E ratio 14.3 · P/S ratio 3.09 · EPS (TTM) 12.58 TWD · Dividend yield 3.9% · Net margin 20.6% · Return on equity 19.2% · Return on assets (EBIT) 15.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 78 out of 100 (low confidence).
What moves the price
The share trades about 18% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at 63%, 4771 screens cheaper than that median.
Fair Value models
Bear219.88 TWDFair Value 293.17 TWDBull366.46 TWD
Price 180.00 TWD · Upside +62.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (4.79 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+16.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.5%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+34.7%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+38.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+34.1%
Dividend (yield on the price)3.9%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.18% → 29%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks
Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score44 · Bottom 25%
Fair Value upside+62.9% · Top 25%
Profitability
Return on equity (12 months)19.2% · Top 25%
Return on assets11.4% · Top 25%
Net margin (12 months)20.6% · Top 25%
Operating margin (12 months)28.9% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)27.2% · Top 25%
Dividend yield (12 months)3.9% · Top 25%
Balance sheet
Debt / equity0.28× · Above median
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Vizionfocus Inc. Fair Value". https://www.fairvalue-calculator.com/stock/4771
Frequently asked questions
Is Vizionfocus Inc. (4771) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 293.17 TWD versus a price of 180.00 TWD, about +63% upside (undervalued).
What is the fair value of 4771?
Our model-based fair value for Vizionfocus Inc. is 293.17 TWD (as of Nov 9, 2026), built from audited fundamentals. The current price: 180.00 TWD.
What is the quality score of 4771?
Vizionfocus Inc. has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Vizionfocus Inc. (4771)?
Our model-based price target is the fair value of 293.17 TWD (as of Nov 9, 2026) from 16 valuation models. Cautious scenario 219.88 TWD, optimistic scenario 366.46 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Vizionfocus Inc. stock forecast for 2026?
Our models put fair value at 293.17 TWD, about +63% upside versus a price of 180.00 TWD (undervalued). Cautious scenario 219.88 TWD, optimistic scenario 366.46 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Vizionfocus Inc. (4771)?
Vizionfocus Inc. reported trailing-twelve-month revenue of about 3.7B TWD (latest available figure, as of Nov 9, 2026).
Does Vizionfocus Inc. pay a dividend?
Vizionfocus Inc. currently shows a dividend yield of 3.89% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Vizionfocus Inc. (4771) and when is the ex-dividend date?
Vizionfocus Inc. pays a dividend of 7.00 TWD per share a year, a dividend yield of 3.9%. The last ex-dividend date was Jul 24, 2026. The payout ratio is 55.6% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Vizionfocus Inc. (4771)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Vizionfocus Inc. it is 293.17 TWD per share (as of Nov 9, 2026), against a price of 180.00 TWD. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Vizionfocus Inc. stock overvalued or undervalued in 2026?
As of Nov 9, 2026, 4771 trades below its calculated fair value: price 180.00 TWD, fair value 293.17 TWD, a gap of about +63% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4771?
No. The price is what the market pays today (180.00 TWD); the fair value is what the company's own numbers justify (293.17 TWD). For Vizionfocus Inc. the two are 113.17 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Vizionfocus Inc. worth?
The market values Vizionfocus Inc. at about 11.4B TWD (market capitalisation, as of Nov 9, 2026). Per share that is 180.00 TWD; our models calculate a fair value of 293.17 TWD per share.
What do the bullish and bearish scenarios say about 4771?
Our models span a range for Vizionfocus Inc.: cautious scenario 219.88 TWD, base 293.17 TWD, optimistic 366.46 TWD per share (as of Nov 9, 2026, price 180.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4771?
Vizionfocus Inc. trades at a price-to-earnings ratio of 14.3 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 293.17 TWD is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2021 to 2025), reported earnings: 23.1. Other multiples: P/B 2.9, P/S 3.1, EV/EBITDA 8.1.
How solid is the balance sheet of Vizionfocus Inc. (4771)?
Balance-sheet figures for Vizionfocus Inc. (as of Nov 9, 2026): return on equity 19.2%, debt of 0.28 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is 4771 from its 52-week high?
Vizionfocus Inc. trades at 180.00 TWD, about 18% below its 52-week high of 219.00 TWD and 10% above the low of 163.91 TWD (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 293.17 TWD is for.
Which stocks are comparable to Vizionfocus Inc.?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Vizionfocus Inc. stock attractive at the current price?
The data as of Nov 9, 2026: price 180.00 TWD, calculated fair value 293.17 TWD (+63%), Quality Score 44/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4771 calculated?
We run Vizionfocus Inc. through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 293.17 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Vizionfocus Inc. currently trades 39% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Vizionfocus Inc. (4771)?
The closing price on Nov 9, 2026 was 180.00 TWD. Our model-based fair value is 293.17 TWD, about +63% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Vizionfocus Inc. right now?
The large discount to fair value meets weak quality (44/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (219.88 TWD). The market is more pessimistic than our downside scenario.
Key figures of Vizionfocus Inc.
How large is the market capitalisation of Vizionfocus Inc. (4771)?
The market capitalisation of Vizionfocus Inc. is 11.4B TWD (≈ $349M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Vizionfocus Inc. (4771)?
The price-to-sales ratio of Vizionfocus Inc. is 3.09 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Vizionfocus Inc. (4771)?
Earnings per share at Vizionfocus Inc. are 12.58 TWD (price ÷ EPS = P/E 14.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Vizionfocus Inc. (4771)?
The dividend yield of Vizionfocus Inc. is 3.9% (payout 55.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Vizionfocus Inc. (4771)?
The net margin of Vizionfocus Inc. is 20.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Vizionfocus Inc. (4771)?
The return on equity (ROE) of Vizionfocus Inc. is 19.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Vizionfocus Inc. (4771)?
On an EBIT basis the return on assets of Vizionfocus Inc. is 15.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Vizionfocus Inc. (4771)?
The operating margin of Vizionfocus Inc. is 28.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Vizionfocus Inc. (4771)?
Revenue at Vizionfocus Inc. is growing +27.2% versus a year earlier (3y avg +23.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Vizionfocus Inc. (4771)?
Earnings per share at Vizionfocus Inc. are growing +11.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Vizionfocus Inc. (4771) generate?
The free cash flow of Vizionfocus Inc. is −78.2M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Vizionfocus Inc. (4771) carry?
The net debt of Vizionfocus Inc. is 597M TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Vizionfocus Inc. in the live analysis
One click puts Vizionfocus Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 9, 2026